Non-peptide neuropeptide y antagonists derived from the histamine H2 agonist arpromidine: Role of the guanidine group

Tatemoto, 1982, 79, 5485 Wahlestedt, 1993, Annu. Rev. Pharmacol. Toxicol., 32, 309, 10.1146/annurev.pa.33.040193.001521 Michel, 1995, J. Hypertens., 13, 385, 10.1097/00004872-199504000-00003 Rudolf, 1994, Eur. J. Pharmacol., 271, R11, 10.1016/0014-2999(94)90822-2 Serradeil-Le Gal, 1995, FEBS Lett., 362, 192, 10.1016/0014-5793(95)00230-7 Doughty, 1992, Bioorg. Med. Chem. Lett., 2, 1497, 10.1016/S0960-894X(00)80416-3 Chaurasia, 1994, J. Med. Chem., 37, 2242, 10.1021/jm00040a018 Michel, 1990, Ann. NY Acad. Sci., 611, 392, 10.1111/j.1749-6632.1990.tb48960.x Buschauer, 1989, J. Med. Chem., 32, 1963, 10.1021/jm00128a045 Michel, 1993, Arch. Pharm., 326, 664 Allen, 1987, 84, 2532 Buschauer, 1989, Arch. Pharm., 322, 165, 10.1002/ardp.19893220310 Sellier, 1992, Liebigs Ann. Chem., 317, 10.1002/jlac.199219920158 Black, 1972, Nature, 236, 385, 10.1038/236385a0 Motulsky, 1988, Am. J. Physiol., 255, E880 Zingel, 1990, Eur. J. Med. Chem., 25, 673, 10.1016/0223-5234(90)90132-M Van Rossum, 1963, Arch. Int. Pharmacodyn. Ther., 299 Douglas, 1978, Arzneim.-Forsch., 28, 1435 Van der Goot, 1991, Vol. 97, 573